Rheumatic Disease Clinics of North America

Article	Citations
Pediatric Rheumatology Comes of Age: Part II	96
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	71
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	49
Contents	37
Copyright	29
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	28
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	26
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	21
Osteoarthritis Treatment Guidelines from Six Professional Societies	21
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis	21
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	19
Forthcoming Issues	19
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	17
COPA Syndrome from Diagnosis to Treatment	16
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota	16
Copyright	15
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	14
Taxonomy of Quality of Care Indicators	14
Contributors	14
Lessons Learned from the COVID-19 Pandemic in Rheumatology	12
The Short and Long of COVID-19	12
Contents	12
Imaging Challenges and Developments in Large-vessel Vasculitis	12
It Takes Oysters to Generate Pearls	11
Newer Immunosuppressants for Rheumatologic Disease	11

Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	11
Vaccinations in Patients with Rheumatic Disease	11
Expanding the Treatment Team	10
Primary Cardiac Involvement in Systemic Sclerosis	10
Copyright	10
De novo Connective Tissue Disorders as Immune-related Adverse Events	9
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events	9
Pulmonary Hypertension Associated with Connective Tissue Disease	9
Scleroderma: Best Approaches to Patient Care	8
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease	8
Rheumatology Pearls for the Primary Care Physician	8
Uveitis in Children and Adolescents	8
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	8
Chronic Nonbacterial Osteomyelitis	7
Preventative Care in Scleroderma	7
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	7
Guideline Development and Implementation in Rheumatic Disease	7
Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases	7
Cardiac MRI in Rheumatic Disease	7
COVID-19 and Rheumatology	7
Charles L Christian	7
Daniel J McCarty, MD: A Giant of Rheumatology	7
Contributors	6
E Carwile LeRoy, MD	6
Contents	6
A Guide to Contemporary Clinical Practice Guidelines	6
Imaging of the Major Salivary Glands in Rheumatic Disease	6
Heart Failure in Rheumatic Disease	6
Imaging of Pulmonary Manifestations of Connective Tissue Disease	6
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD	6
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus	5
Beyond Coronary Artery Disease	5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	5
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	5
The Challenges of New Biologic Therapies in Pediatrics	5
Forthcoming Issues	5
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy	5
Copyright	5
Copyright	5
Contributors	5
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus	5
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	5
Contents	4
The Role of Psychology in Pediatric Rheumatic Diseases	4
Genetic Defects in Early-Onset Inflammatory Bowel Disease	4
Management and Cure of Gouty Arthritis	4
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	4
Role of Environment in Pediatric Rheumatic Diseases	4
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	4
Treatment Guidelines in Pediatric Rheumatic Diseases	4

Dual-Energy Computed Tomography Applications in Rheumatology	4
SARS-CoV-2 Infection and COVID-19 in Children	4
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma	4
Treatment Guidelines in Gout	4
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	4
Copyright	4
CARRA	4
Cardiovascular Health in Pediatric Rheumatologic Diseases	4
Patient Engagement in Pediatric Rheumatology Research	4
Health Care Utilization	3
Imaging in Inflammatory Bowel Disease	3
Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica	3
The GRADE Method	3
Achieving Precision Medicine in Psoriatic Arthritis	3
Pediatric Rheumatic Disease in Lower to Middle-Income Countries	3
Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis	3
Interstitial Lung Disease	3
Instrumental Substance Use Among Youth with Rheumatic Disease—A Biopsychosocial Model	3
Pediatric Rheumatology Comes of Age: Part I	3
Expanding IPEX: Inborn Errors of Regulatory T Cells	3
Forthcoming Issues	3
Technology to Assess and Treat Pain in Pediatric Rheumatology	3
Mental Health in Pediatric Rheumatology	2
Training the Next Generation of Rheumatologists	2
Forthcoming Issues	2
Forthcoming Issues	2
Perioperative Management of Rheumatic Disease and Therapies	2
J. Claude Bennett, MD	2
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis	2
Pediatric Rheumatology Comes of Age: Part II	2
COVID-19 in Pediatrics	2
Forthcoming Issues	2
Systemic Diseases and Heart Block	2
Preface	2
Nathan Zvaifler	2
Targeting Environmental Risks to Prevent Rheumatic Disease	2
Contents	2
Imaging in Juvenile Idiopathic Arthritis	2
Early Sexual Health and Reproductive Implications in Pediatric Rheumatic Diseases	2
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis	2
Contributors	2
Outcome Measures in Pediatric Rheumatic Disease	2
Precision Medicine	2
Contributors	2
Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis	1
Forthcoming Issues	1
Treatment Guidelines in Vasculitis	1
Contributors	1
Juvenile Fibromyalgia	1
The Giants Of Rheumatology	1
The Promises and Perils of Social Media for Pediatric Rheumatology	1
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy	1
The Current and Future of Biomarkers of Immune Related Adverse Events	1
Long COVID for the Rheumatologist	1
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis	1
Highlights of Interdisciplinary Care in Rheumatology	1
Transitioning to Adulthood with a Rheumatic Disease	1
Contributors	1
Forthcoming Issues	1
Pediatric Rheumatology Comes of Age: Part I	1
Vasculitis	1
Treatment of Vascular Complications in Systemic Sclerosis	1
Cardiovascular Disease in Large Vessel Vasculitis	1
Treatment of Inflammatory Arthritis in Systemic Sclerosis	1
Rheumatic Complications of Immune Checkpoint Inhibitors	1
Targeted Treatment of Diseases of Immune Dysregulation	1
Foreword	1
Recent Updates in Juvenile Spondyloarthritis	1
Imaging in Rheumatology	1
Forthcoming Issues	1
Gerald P Rodnan	1
Axial Imaging in Spondyloarthritis	1
Foreword	1
Contributors	0
Type I Interferonopathies	0
Systemic Autoinflammatory Diseases	0
Environmental Triggers for Vasculitis	0
Preventative Care in Scleroderma	0
Pediatric Rheumatology Comes of Age: Part II	0
Managing Cardiovascular Risk in Patients with Rheumatic Disease	0

Environmental Risks for Spondyloarthropathies	0
The Microbiome in Rheumatologic Diseases	0
The Emerging Telehealth Landscape in Pediatric Rheumatology	0
Psoriatic Arthritis Updates	0
Contents	0
Combined Dermatology/Rheumatology Clinics for Management of Psoriatic Disease	0
Interventions to Improve COVID-19 Vaccine Hesitancy	0
Contents	0
Environmental Triggers for Rheumatic Diseases	0
Environmental Risks for Systemic Sclerosis	0
Juvenile Idiopathic Arthritis Treatment Updates	0
Contributors	0
Axial Psoriatic Arthritis	0
Emerging Concepts in Immune Dysregulation	0
Imaging in Rheumatology	0
Eric Bywaters and Barbara Ansell	0
The Burden of Post-Acute Sequelae of Coronavirus Disease 2019 in Individuals with Rheumatic Diseases	0
Vasculitis Mimics and Other Related Conditions	0
Vasculitis	0
Environmental Triggers for Rheumatic Diseases	0
Challenges in Developing Treatment Guidelines in Psoriatic Arthritis	0
Microbiome and Rheumatic Diseases	0
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis	0
Guideline Development and Implementation in Rheumatic Disease	0
Contributors	0
Vascular, Soft Tissue, and Musculoskeletal Imaging in Systemic Sclerosis	0
Central Nervous System Imaging in Rheumatic Diseases	0
The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis	0
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	0
Copyright	0
Copyright	0
Emerging Concepts in Immune Dysregulation	0
Immune Checkpoint Inhibitor-induced Sicca Syndrome	0
Forthcoming Issues	0
Giant Cell Arteritis and Polymyalgia Rheumatica	0
Lessons on Telemedicine in Rheumatology	0
Lessons from Carl M. Pearson 1919 – 1981	0
Edmund Lawrence Dubois (1923–1985)	0
Naomi Rothfield, MD, MACR	0
The Future of Vasculitis	0
Mental Health Considerations in Chronic Disease	0
Copyright	0
John R. Ward, MD: Pioneer—Clinical Trials in Rheumatology	0
Vasculitis and Pregnancy	0
Forthcoming Issues	0
Lung Microbiome in Autoimmune-Associated Interstitial Lung Disease	0
The Temporomandibular Joint in Juvenile Idiopathic Arthritis	0
Imaging of Rheumatic Diseases Affecting the Lower Limb	0
Cardiovascular Complications of Chronic Rheumatic Diseases	0
Gastrointestinal Tract Considerations: Part II	0
Rheumatic Immune-Related Adverse Events: Current Clinical Imperatives Underpin Future Novel Insights	0
Copyright	0
Immunotherapy Toxicity Management in Clinical Practice	0
Suppressor of Cytokine Signaling 1 Haploinsufficiency	0
Forthcoming Issues	0
Rheumatoid Arthritis	0
Rheumatology Pearls for the Primary Care Physician	0
Disparities in Pediatric Rheumatic Diseases	0
Patient Experience of Systemic Sclerosis–Related Calcinosis	0
Scleroderma Skin	0
Contributors	0
Highlights of Interdisciplinary Care in Rheumatology	0
Autoimmune Connective Tissue Diseases: Systemic Lupus Erythematosus and Rheumatoid Arthritis	0
Juvenile Localized Scleroderma	0
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases	0
Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders	0
Best Approaches to the Care of Systemic Sclerosis Patients	0
Pediatric Rheumatology Comes of Age: Part I	0
How the American College of Rheumatology Develops Guidelines	0
Environmental Triggers of Hyperuricemia and Gout	0
New Developments in Imaging in Crystalline Arthritis	0
Central Nervous System Vasculitis	0
Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases	0
Contents	0
New and Emerging Rheumatic Diseases	0
Scleroderma: Best Approaches to Patient Care	0
Rheumatic Immune-related Adverse Events	0
Forthcoming Issues	0
Gut and Joint Microbiomes	0
Foreword	0
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development	0
Isolated Aortitis	0
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients	0
Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression	0
Forthcoming Issues	0
Contents	0
Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases	0
Systemic Lupus Erythematosus Risk	0
Coronavirus Disease-2019 in the Immunocompromised Host	0
Newer Immunosuppressants for Rheumatologic Disease	0
Imaging Revolutions in Modern Rheumatology	0
Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy	0
The Impact of Coronavirus Disease 2019 on Patients Living with Rheumatic Diseases	0
Forthcoming Issues	0
Environmental Risks for Inflammatory Myopathies	0